Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine-Carboplatin vs Gemcitabine-Oxaliplatin in Urothelial Carcinoma
NCT01487915Phase 2Unknown
- Sponsor
- Asan Medical Center
- Start
- Oct 2010
- Primary completion
- Jun 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in urothelial carcinoma (UC), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01487915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01487915.